Stay updated on Cannabidiol in Dravet & Lennox-Gastaut Clinical Trial
Sign up to get notified when there's something new on the Cannabidiol in Dravet & Lennox-Gastaut Clinical Trial page.

Latest updates to the Cannabidiol in Dravet & Lennox-Gastaut Clinical Trial page
- Check6 days agoChange DetectedRevision label on the page has been updated from v3.5.3 to v3.5.4. This indicates a minor update to the site/versioning and does not alter the study content.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision: v3.5.3 was added and Revision: v3.5.2 was removed. This indicates a new software release version for the site, representing a platform update rather than changes to the study page content.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check42 days agoChange DetectedNo additions or deletions observed; the page content and layout appear unchanged between versions.SummaryDifference0.1%

- Check49 days agoChange DetectedAdded the alias 'Severe myoclonic epilepsy in infancy' to the Conditions section to reflect SMEI/Dravet terminology.SummaryDifference0.1%

- Check56 days agoChange DetectedRemoved 'Dravet syndrome' from the list of conditions on the Study Details page.SummaryDifference0.0%

Stay in the know with updates to Cannabidiol in Dravet & Lennox-Gastaut Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cannabidiol in Dravet & Lennox-Gastaut Clinical Trial page.